https://seekingalpha.com/news/4123061-cantor-sees-tango-benefitting-from-ideayas-positive-data?source=feed_sector_healthcare
Jul 09, 2024 - Cantor Fitzgerald said it sees Tango (TNGX) benefitting from Ideaya’s (IDYA) positive data for its MAT2A inhibitor IDE397 in the treatment of certain cancers. Read more here.
0
sa:5238554015458484546
0
https://www.zacks.com/stock/news/2298467/wall-street-analysts-see-a-35-78-upside-in-everquote-ever-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2298467
Jul 09, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 35.8% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
zc:6525833363728129766
0
https://www.zacks.com/stock/news/2298463/wall-street-analysts-see-a-30-14-upside-in-intra-cellular-itci-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2298463
Jul 09, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 30.1% in Intra-Cellular (ITCI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
zc:1476045226616575006
0
https://www.zacks.com/stock/news/2298425/wall-street-analysts-see-applied-materials-amat-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2298425
Jul 09, 2024 - According to the average brokerage recommendation (ABR), one should invest in Applied Materials (AMAT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
zc:-8149971612414136178
0
https://www.cnbc.com/2024/07/08/chance-of-biden-dropping-out-of-presidental-race-is-40percent-stifel-says.html
Jul 08, 2024 - Brian Gardner, Stifel's chief Washington policy strategist, said it is a "make or break week" for President Joe Biden's campaign.
0
cnbc:4391883244226995335
0
https://www.zacks.com/stock/news/2297986/wall-street-analysts-see-kyndryl-holdings-inc-kd-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2297986
Jul 08, 2024 - The average brokerage recommendation (ABR) for Kyndryl Holdings, Inc. (KD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
zc:2648991002086594203
0
https://www.ocregister.com/2024/07/07/clippers-like-the-talent-and-enthusiasm-they-see-in-cam-christie-their-youngest-newest-player/
Jul 07, 2024 - The 18-year-old brother of the Lakers' Max Christie says he intends to establish his own identity and style of play.
0
ocr:-5803914828722394230
0
https://www.cnbc.com/2024/07/07/top-wall-street-analysts-see-attractive-prospects-for-these-3-stocks-.html
Jul 07, 2024 - TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including Micron Technology and Amazon.
0
cnbc:-7218998555249019485
0
https://seekingalpha.com/news/4122402-small-mid-size-biotechs-could-see-ma-action-h2?source=feed_sector_healthcare
Jul 06, 2024 - The second half of 2024 could see increased dealmaking in the biotech sector due to upcoming patent cliffs for large pharmas. Read more here.
0
sa:-7559803036044619814
0
https://www.fool.com/investing/2024/07/04/nvidia-continues-to-see-strong-demand-for-its-arti/?source=iedfolrf0000001
Jul 04, 2024 - Nvidia's AI chips, the H100 and H200, continue to see healthy demand.
0
fool:-8320220286200996124
0